A New Selection Strategy to Enrich Dopaminergic Neurons Facilitates Comparisons Between Patient iPSC-Derived Lines
Authors:
- Ellen HertzEHEllen Hertz
- Gani PerezGPGani Perez
- Krystyna RytelKRKrystyna Rytel
- Martha KirbyMKMartha Kirby
- Stacie AndersonSAStacie Anderson
- Stephen WincovitchSWStephen Wincovitch
- Tim AhfeldtTATim Ahfeldt
- Joel BlanchardJBJoel Blanchard
- Ying HaoYHYing Hao
- Ziyi LiZLZiyi Li
- Kate AndershKAKate Andersh
- Yue Andy QiYQYue Andy Qi
Open Access
- 22 October 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9394
Abstract
Comparative studies of dopaminergic (DA) neurons differentiated from induced pluripotent stem cells (iPSCs) derived from patients discordant for parkinsonism, especially siblings, provide a valuable model to explore factors underlying Parkinson disease (PD) pathogenesis. However, such studies are complicated by the inherent heterogeneity in differentiation efficiency among iPSC lines derived from different individuals. To address this technical challenge, we devised a selection strategy to enrich DA neurons expressing tyrosine hydroxylase (TH). A neomycin resistance gene (neo) was inserted at the C-terminus of the TH gene, placing its expression under the endogenous promoter. Using iPSC-derived neurons from a healthy individual (HT711), we achieved selective enrichment of TH+ neurons through geneticin selection without compromising differentiation capacity, as demonstrated by Western blots, immunocytochemistry and flow cytometry. We then applied the method to iPSCs derived from two siblings of HT711, one with Gaucher disease (GD) alone and one with both PD and GD. Quantification of multiple DA neuron markers through whole-cell proteomics confirmed their comparable enrichment in the three lines, demonstrating that the new method can be applied to iPSC lines from different individuals to standardize DA neuron cultures. While we focus on methodological developments here, a companion analysis of the same whole-cell proteomics dataset, examining molecular features potentially associated with disease statuses, has been reported separately.Keywords
Funding Information
- National Human Genome Research Institute
- Center for Alzheimer’s and Related Dementias
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
- Aligning Science Across Parkinson's (ASAP-000458)
This publication has 32 references indexed in Scilit:
- Evaluation of Induced Pluripotent Stem Cell‐Derived Dopaminergic Neurons from Siblings with Gaucher Disease Discordant for ParkinsonismMovement Disorders, 2025
- Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs)Stem Cell Reviews and Reports, 2024
- A fully automated FAIMS-DIA mass spectrometry-based proteomic pipelineCell Reports Methods, 2023
- A reference human induced pluripotent stem cell line for large-scale collaborative studiesCell Stem Cell, 2022
- Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational UseCell Stem Cell, 2021
- Pluripotent Stem Cell-Based Cell Therapy—Promise and ChallengesCell Stem Cell, 2020
- Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivoStem Cells Translational Medicine, 2020
- Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neuronsStem Cell Research, 2019
- Single-Cell Analysis Reveals a Close Relationship between Differentiating Dopamine and Subthalamic Nucleus Neuronal LineagesCell Stem Cell, 2017
- Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem CellsNeuron, 2013